A Study of Patients Receiving High-Dose Rate Brachytherapy
Phase 2 Completed
43 enrolled 13 charts
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Phase 2 Completed
40 enrolled 13 charts
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
Phase 2 Completed
22 enrolled
KEYVIBE-005
Phase 2 Completed
613 enrolled
P204
Phase 2 Completed
111 enrolled 22 charts
Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer
Phase 2 Completed
78 enrolled
Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer
Phase 2 Completed
146 enrolled
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Phase 2 Completed
25 enrolled 15 charts
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Phase 2 Completed
38 enrolled 12 charts
Study of AK112 in the Treatment of Advanced Gynecological Tumors
Phase 2 Completed
53 enrolled
A Study of Nivolumab in Selected Uterine Cancer Patients
Phase 2 Completed
35 enrolled 8 charts
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Phase 2 Completed
20 enrolled 12 charts
UTOLA
Phase 2 Completed
147 enrolled
SPIRIT
Phase 2 Completed
121 enrolled 12 charts
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Phase 2 Completed
64 enrolled 13 charts
FUCHSia
Phase 2 Completed
17 enrolled
MiMe-A
Phase 2 Completed
85 enrolled
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
Phase 2 Completed
39 enrolled 8 charts
Clovis-001
Phase 2 Completed
49 enrolled 13 charts
DECENDO
Phase 2 Completed
8 enrolled
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
Phase 2 Completed
47 enrolled
ENDOPIK
Phase 2 Completed
24 enrolled
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Phase 2 Completed
35 enrolled
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
Phase 2 Completed
133 enrolled 16 charts
Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma
Phase 2 Completed
16 enrolled
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Phase 2 Completed
61 enrolled 13 charts
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
28 enrolled 12 charts
SIGN
Phase 2 Completed
116 enrolled 21 charts
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Phase 2 Completed
30 enrolled 15 charts
Pembro/Carbo/Taxol in Endometrial Cancer
Phase 2 Completed
46 enrolled 13 charts
Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer
Phase 2 Completed
200 enrolled
A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer
Phase 2 Completed
241 enrolled 22 charts
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.
Phase 2 Completed
5 enrolled 8 charts
PRIMMO
Phase 2 Completed
43 enrolled
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Phase 2 Completed
13 enrolled
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Phase 2 Completed
33 enrolled
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Phase 2 Completed
15 enrolled 12 charts
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
52 enrolled 10 charts
Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
31 enrolled 13 charts
VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
49 enrolled 13 charts
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Phase 2 Completed
73 enrolled 13 charts
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Phase 2 Completed
36 enrolled 5 charts
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Phase 2 Completed
106 enrolled 14 charts
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Phase 2 Completed
73 enrolled 19 charts
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
Phase 2 Completed
60 enrolled
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Phase 2 Completed
100 enrolled
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
Phase 2 Completed
31 enrolled 9 charts
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Phase 2 Completed
41 enrolled 10 charts
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Phase 2 Completed
44 enrolled 7 charts